Extramural Funding Opportunities

The following is a compilation of funding opportunities for research studies. Funding sources vary from Limited Submission from within the University, to private as well as governmental sponsors. NIH opportunities for funding will be listed below, as well as on the NIH Announcements page. Those opportunities closest to the date of application will be listed at the top of the page. Students may find information on funding specifically for them on the Student News page. Selected employment opportunities presented to the Office of Research & Graduate Education will be posted on this page as they become available. These employment opportunities can be found towards the bottom of the page, following all of the funding opportunities.


Funding at NIH - Grants.gov

-more information-

NIH Weekly Funding Opportunities

-Funding opportunities list-

NIH - National Institute of Allergy and Infectious Diseases

-Funding opportunities list-

Funding Opportunities at the National Science Foundation (NSF)

-more information-

USDA/NIFA Funding Opportunities

-more information-

NIAID Funding News

-June 7th, 2017-



AALAS Accepting Applications for Grants

The American Association for Laboratory Animal Science is accepting grant applications for research designed to enhance scientific knowledge in laboratory animal health and welfare. The AALAS awards small grants of up to $7,500 and standard grants of up to $50,000.

Because the mission of the AALAS Grants for Laboratory Animal Science Program includes promoting collaborative efforts by the AALAS membership within the broader scientific community, the principal investigator must be an AALAS member, but co-investigators do not have to be AALAS members. There are no geographic restrictions with regard to the investigators or the institution, so international submissions are welcomed.  

Applications are due Feb. 1, 2018 at 11:59 pm CST.

-More Information-

UC Cancer Research Coordinating Committee – Request for Proposals

The Cancer Research Coordinating Committee (CRCC) is pleased to issue a Request for Proposals for the awards for 2019.  Administered by UC Research Initiatives in the UC Office of the President, the CRCC is a systemwide, faculty-directed cancer research program that provides one-year seed grants for topics in any discipline that address any aspect of cancer, including its origins, prevention and cure. CRCC funds support meritorious research spanning all areas from basic research to applied clinical and community-based research in any field relevant to cancer. Currently, the CRCC awards grants to:

  • New UC faculty to initiate cancer research projects;
  • Established investigators in other areas of research to initiate cancer research projects;
  • Established cancer investigators to initiate cancer studies in new areas.

Attached is the CRCC Request for Proposals for award year 2019. Proposals must be submitted by a member of the Academic Senate at one of the ten UC campuses who serves as the PI for the award. Note: A Letter of Intent (LOI) is required. Please refer to the attached RFP for funding priorities, eligibility, application guidelines and additional information.

Key Dates:

Applicant Teleconference (optional)*:                   Thursday, January 11, 2018 at 10:00 AM

(register here)                     

Required Letters of Intent Due:                             Thursday, January 25, 2018 at 12:00 PM PT

Notification of LOI Decision:                                 by Monday, February 5, 2018         

Full Proposals Due:                                               Thursday, April 5, 2018

*The applicant teleconference is strongly encouraged for new applicants and for previous applicants who are not familiar with proposalCENTRAL.

Additional Information:

For questions on program scope and priorities, please contact:  UCRI@ucop.edu

Administrative questions regarding the application process may be directed to: RGPOGrants@ucop.edu

We also encourage you to check our website for any updates or announcements.

Pew Charitable Trusts - Request for Proposals

The Pew Charitable Trusts have just announced two Requests for Proposals related to antimicrobial resistance in food producing animals. The RFPs are to review the available scientific literature to see what scientific evidence exists, where the data gaps are, and ideally how to close them (see below for more information).

Interested parties should email expressions of interest to PewRFPantibiotics@pewtrusts.org by November 27 to receive the RFP.

Pew will accept submissions from researchers outside the U.S.

The deadline for submission of proposals is 5:00 pm EST on January 25, 2018. 

What Practices Reduce Antibiotic Use in Food Animals?

Pew to support analysis of existing scientific data, identify gaps

Antibiotics are crucial to protecting the health of people and animals, but any use endangers their efficacy as bacteria develop resistance to them over time. Each year, at least 23,000 Americans die and some 2 million are sickened from antibiotic-resistant bacterial infections. To help preserve the effectiveness of these lifesaving drugs, Pew’s antibiotic resistance project works to promote antibiotic stewardship in both human medicine and animal agriculture. In the case of food-producing animals, this means using antibiotics judiciously and trying to prevent animals from becoming sick in the first place.

Good animal management practices—such as optimal nutrition, housing, and age at weaning—can lead to fewer diseases and thereby reduce the need to use antibiotics. Yet there has been little rigorous analysis of the existing scientific evidence that quantifies how different management practices affect animal health and antibiotic use. Pew is committed to supporting research that will survey the existing scientific literature and address three key questions.

First, what scientific evidence is available to show the impact of different practices on disease prevalence and the need to use medically important antibiotics in food animals? Second, what key data gaps exist in the scientific evidence, and how do they impede the ability to make animal management decisions that are grounded in science? And third, what research is needed to fill those gaps?

Pew seeks to support research studies that can help answer these questions, inform strategies to reduce the use of antibiotics without harm to animal health, and guide future scientific studies. If you or your organization is interested in learning more about this research opportunity, please email PewRFPantibiotics@pewtrusts.org for the Request for Proposals (RFP) form.

To preserve these lifesaving drugs and protect both human and animal health, we need to survey the science that has already been done, find the gaps in that knowledge, and fill in the missing pieces.

Karin Hoelzer, a veterinarian, works on The Pew Charitable Trusts’ antibiotic resistance and safe food projects.

Any entity interested in receiving the full RFP and being given the opportunity to submit a proposal should submit an expression of interest (EOI) by 5 p.m. EST on November 27, 2017, by email to PewRFPantibiotics@pewtrusts.org. The Pew Charitable Trusts will distribute the full RFP with additional details on timing, evaluation and proposal criteria, terms and conditions, and due diligence to those entities that have submitted an EOI by such date, and any other entities at its discretion. EOIs are not binding; submission of an EOI does not obligate a respondent to submit a proposal.

Is Antibiotic Use Effective to Prevent Disease in Food-Producing Animals?

Pew to support analysis of existing scientific data, identify gaps

Antibiotics are crucial to protecting the health of people and animals, but any use endangers their efficacy as bacteria develop resistance to them over time. Each year, at least 23,000 Americans die and some 2 million are sickened from antibiotic-resistant bacterial infections. To help preserve the effectiveness of these lifesaving drugs, Pew’s antibiotic resistance project works to promote antibiotic stewardship in both human medicine and animal agriculture. For food-producing animals, this means trying to prevent animals from becoming sick and using antibiotics judiciously when they are needed.

“Disease prevention” is defined as the administration of antibiotics to animals that are not exhibiting clinical signs of disease but are at increased risk of infection. This practice is controversial, and some countries have moved to restrict the use of medically important antibiotics for disease prevention. Yet there has been little rigorous analysis in the U.S. of the existing scientific evidence regarding the efficacy of administering medically important antibiotics to food animals for prevention purposes. Pew is committed to supporting research that will survey and synthesize available data on the efficacy of preventive uses of medically important antibiotics in food-producing animals in order to provide a scientific foundation to this debate. Specifically, the research will address three key questions.

First, what scientific evidence is available to show a demonstrated animal health benefit from different preventive uses of medically important antibiotics? Second, what key data gaps exist in the scientific evidence, and how do they impede the ability to make a determination about the efficacy of preventive uses of antibiotics? And third, what research is needed to fill those gaps?

Pew is planning to support research to help answer these questions, inform efforts to reduce the use of antibiotics without harm to animal health, and guide future scientific studies. If you or your organization is interested in learning more about this research opportunity, please email PewRFPantibiotics@pewtrusts.org for the Request for Proposals (RFP) form.

To preserve these lifesaving drugs and protect both human and animal health, we need to synthesize the science that has already been done, find the gaps in that knowledge, and fill in the missing pieces.

Karin Hoelzer, a veterinarian, works on The Pew Charitable Trusts’ antibiotic resistance and safe food projects.

Any entity interested in receiving the full RFP and being given the opportunity to submit a proposal should submit an expression of interest (EOI) by 5 p.m. EST on November 27, 2017, by email (PewRFPantibiotics@pewtrusts.org). The Pew Charitable Trusts (“Pew”) will distribute the full RFP with additional details on timing, evaluation and proposal criteria, terms and conditions, and due diligence to those entities that have submitted an EOI by such date, and any other entities at its discretion. EOIs are not binding; submission of an EOI does not obligate a respondent to submit a proposal. 

Morris Animal Foundation Announces Call for Small Companion Animal Proposals

Morris Animal Foundation is now accepting proposals for Established Investigator, First Award, Fellowship Training and Pilot Study grants on topics relevant to small companion animal (dogs and cats) health and welfare. 

All proposals relevant to the mission of the Foundation will be given equal consideration for funding. However, this year, we are particularly interested in inviting proposals that address the following topics:

  1. Prevention, treatment and diagnosis of heartworm disease
  2. Genetics and epigenetics of health and disease
  3. Gut health and the association of microbiome with health outcomes

Proposals are due Wednesday, March 14, 2018, by 11:59 p.m. EST.

Learn more about each of these grant types and the application process for each.

Please note that this call for proposals is only for Established Investigator, First Award, Fellowship Training and Pilot Studies relating to small companion animals (dogs and cats).

Please submit proposals using these guidelines.

UC-HBCU 2017-18 Announcement and Call for Applications

The Office of the President is pleased to announce the 2017-18 Request for Proposals for the UC-HBCU Initiative. As you may recall, this is a systemwide initiative designed to assist UC faculty interested in developing and encouraging efforts to achieve a more inclusive educational environment of excellence. The goal of the UC-HBCU Initiative is to increase the number of scholars from Historically Black Colleges and Universities completing UC academic doctoral programs. UC faculty grants are available to support HBCU students conducting summer research with UC faculty at a UC campus; and also support departmental efforts to facilitate greater faculty collaboration between UC and HBCU institutions and to increase applications from HBCU scholars to UC PhD programs. Again this year, Principal Investigators may include 1/9 (1/12 for fiscal-year faculty PIs (UCSF), subject to the terms of APM-661 -http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-661.pdf ) summer salary to help support their efforts during the summer(s) in which the projects are active. These funds are being provided by each of the chancellors as a commitment to valuing faculty diversity work at their campus. We hope this will facilitate faculty continuing to undertake this important work to strengthen UC.

Since 2012, UC has hosted over 400 HBCU scholars across 9 UC campuses. There are currently forty-two PhD students and two academic master’s students enrolled (one PhD and five master’s students have already graduated) across seven UC campuses as a direct result of this Initiative. As you know, building relationships and cultivating greater enrollment of HBCU scholars at UC is a long-term investment. Project progress reports are required annually of Principal Investigators and program outcomes are evaluated.

2017-18 UC-HBCU Initiative - Call for Proposals (pdf)<http://www.ucop.edu/uc-hbcu-initiative/faculty-grants/index.html>

2017-18 UC-HBCU Initiative - Application Instructions & Forms<http://www.ucop.edu/uc-hbcu-initiative/faculty-grants/application-instructions-and-templates/index.html>

Faculty Applicant Webinar<http://www.ucop.edu/uc-hbcu-initiative/faculty-grants/uc-faculty-applicant-webinar/index.html>

France-Berkeley Fund - January 2018 Call for Proposals

The application deadline for the France-Berkeley Fund awards is January 31, 2018:

https://fbf.berkeley.edu/france-berkeley-fund-application-2018-overview

Innovative Learning Technology Initiative (ILTI) - Request for Proposals

The ILTI RFP 6 opened on Monday, July 3, 2017 and will remain open until Monday, April 2, 2018 at 6 PM, Pacific Time. The application and instructions on how to submit a proposal can be found at: https://proposalcentral.altum.com/default.asp.

Specific information about RFP 6 can be found at: http://www.ucop.edu/innovative-learning-technology-initiative/proposals/index.html. Additional information about ILTI is available here: http://www.ucop.edu/academic-affairs/innovative-learning-technology-initiative/index.html.

For proposal development support, please contact Marco Molinaro (mmolinaro@ucdavis.edu) or Kem Saichaie (kemsaiachaie@ucdavis.edu) in the Center for Educational Effectiveness.

NIH – NIAID Funding Opportunity

PA-17-307, Administrative Supplements for Research on Dietary Supplements (Admin Supp)

PA-17-306, Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)

PA-17-302, PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])

PA-17-303, PHS 2017-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])

PA-17-305, Imaging the Persistent HIV Reservoir (R01)

PA-17-306, Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21) 

PA-17-307, Administrative Supplements for Research on Dietary Supplements (Admin Supp)

PA-17-248 Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated With Cancer Immunotherapy (Admin Supp).

RFP-NIAID-DMID-NIHAI2017087 Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases

PAR-17-332, Small Grants on Primary Immunodeficiency Diseases (R03)

PAR-17-333, Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)

PAR-17-438, Assay Development and Screening for Discovery of Chemical Probes or Therapeutic Agents (R01)